{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:06:40Z","timestamp":1762078000834},"reference-count":19,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1016\/s0264-410x(99)00264-9","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:18:44Z","timestamp":1027646324000},"page":"728-735","source":"Crossref","is-referenced-by-count":14,"title":["The immunogenicity in humans of a botulinum type F vaccine"],"prefix":"10.1016","volume":"18","author":[{"given":"Vicki A","family":"Montgomery","sequence":"first","affiliation":[]},{"given":"Richard S","family":"Makuch","sequence":"additional","affiliation":[]},{"given":"J.Edward","family":"Brown","sequence":"additional","affiliation":[]},{"given":"Dallas C","family":"Hack","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0264-410X(99)00264-9_BIB1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Immunologic response of man to purified pentavalent ABCDE botulinum toxoid","volume":"90","author":"Fiock","year":"1963","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.88.3.277","article-title":"Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid","volume":"88","author":"Fiock","year":"1962","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB3","series-title":"Botulism. Proceedings of a symposium","first-page":"113","article-title":"Botulinum toxoids","author":"Cardella","year":"1964"},{"key":"10.1016\/S0264-410X(99)00264-9_BIB4","series-title":"Immunobiologic agents and drugs available from the Centers for Disease Control. Descriptions, Recommendations, Adverse Reactions, and Serologic Response","author":"Ellis","year":"1982"},{"key":"10.1016\/S0264-410X(99)00264-9_BIB5","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1128\/JCM.26.11.2351-2356.1988","article-title":"Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay","volume":"26","author":"Siegel","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1128\/AEM.15.6.1316-1323.1967","article-title":"Characteristics of Clostridium botulinum type F Isolated from the Pacific Coast of the United States","volume":"15","author":"Eklund","year":"1967","journal-title":"Appl. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AEM.29.5.598-603.1975","article-title":"Purification and properties of Clostridium botulinum type F toxin","volume":"29","author":"Yang","year":"1975","journal-title":"Appl. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/109.2.107","article-title":"Clostridium Botulinum type F with recent observations on other types","volume":"109","author":"Dolman","year":"1961","journal-title":"J. Infec. Dis."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1699-0463.1960.tb04741.x","article-title":"Preliminary report on the isolation of an apparently new type of Clostridium botulinum","volume":"48","author":"M\u00f8ller","year":"1960","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JCM.27.8.1906-1908.1989","article-title":"Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid","volume":"27","author":"Siegel","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AEM.31.2.234-242.1976","article-title":"Toxoid of Clostridium botulinum type F: purification and immunogenicity studies","volume":"31","author":"Hatheway","year":"1976","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB12","first-page":"161","article-title":"Immunogenic activity of the combined botulinum toxoids","volume":"22","author":"Trembowler","year":"1970","journal-title":"Exp. Med. Microbiol."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/bj2680123","article-title":"Botulinum type F neurotoxin: large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes","volume":"268","author":"Wadsworth","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB14","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0041-0101(95)00113-1","article-title":"Immunochemical characterization of type A botulinum neurotoxin in its purified and complexed forms","volume":"34","author":"Singh","year":"1996","journal-title":"Toxicon."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB16","first-page":"141","article-title":"In vitro assays for botulinum toxin and antitoxins","volume":"64","author":"Shone","year":"1986","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01971528408062995","article-title":"Comparison of ELISA and toxin neutralization for the determination of tetanus antibodies","volume":"5","author":"Hagenaars","year":"1984","journal-title":"J. Immunoas."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB18","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Inf. Immun."},{"key":"10.1016\/S0264-410X(99)00264-9_BIB19","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Inf. Imm."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X99002649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X99002649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T10:38:42Z","timestamp":1681641522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X99002649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":19,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["S0264410X99002649"],"URL":"https:\/\/doi.org\/10.1016\/s0264-410x(99)00264-9","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}